|
|
 |
|
Viewing report
|
|
|
|
DePuy Medical Device Company Intelligence Report
Espicom Business Intelligence Ltd, April 2011, Pages: 74
Headquartered in Raynham, Massachusetts and Warsaw, Indiana, in the US, Johnson & Johnson's DePuy franchise is one of the world's leading orthopaedic companies and the oldest manufacturer of orthopaedic implants in the US. DePuy's products are primarily used by orthopaedic specialists and spinal neurosurgeons to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, trauma and sports-related injuries. The group also provides solutions for neurosurgical and neurovascular care.
The DePuy group consists of the following companies:-
DePuy Orthopaedics – a leading manufacturer of orthopaedic devices, including hip, knee and extremity replacements, bone cement, trauma solutions, orthobiologics and operating room products. Its portfolio consists of more than 200 products and solutions, including: Pinnacle Hip Solutions with TrueGlide technology, allowing the body to create a thin film of lubrication between surfaces; the aSphere Contoured Metal Head hip replacement solution designed to approximate the shaping that occurs during the in vivo run-in wear phase; the Sigma Knee System, available in partial, fixed and mobile platforms; and TrueMatch Personalised Solutions, for patient-specific instrumentation. DePuy Orthopaedics is based in DePuy's headquarters in Warsaw.
DePuy Spine – the second-largest spine company in the world with a portfolio of spinal care products that address key areas including cervical, ageing spine, deformity, minimally-invasive surgery and biologics. The company's solutions include: the Expedium Spine System for deformity; the Confidence Spinal Cement System for vertebral compression fractures; the Viper System, claimed to be the only minimally-invasive system that can be used to treat both the thoracic and lumbar spine; and the Cougar LS Lateral Cage System, which is used in the far lateral approach. DePuy Spine is headquartered in Raynham.
DePuy Mitek – specialises in orthopaedic sports medicine products, soft tissue repair devices and minimally-invasive and arthroscopic solutions. Its portfolio includes the high-strength, partially absorbable Orthocord suture; and OrthoVisc therapy to treat knee osteoarthritis pain, as well as a range of bioreplaceable fixation devices made with the proprietary biocomposite material, Biocryl Rapide. DePuy Mitek has its headquarters in Raynham.
Codman & Shurtleff – also headquartered in Raynham, is a neuroscience and neurovascular company that focuses on diagnosis and treatment of neurological disorders, including adult and paediatric hydrocephalus, chronic pain, aneurysms and cerebral arteriovenous malformations. In January 2009, Cordis' Neurovascular division, which supplied products for the neurovascular management of strokes, became a business unit of Codman & Shurtleff. The integration of this business – to form Codman Neurovascular – created the platform for a global neuroscience device company. Codman & Shurtleff's product portfolio includes programmable shunt systems, drug pumps, and neurovascular coils and catheters. In 2010, the company received a CE mark for the Orbit Galaxy stretch-resistant coil to treat brain aneurysms and approval for its Enterprise neurovascular system in Japan.
Three strategic acquisitions in 2006 broadened DePuy's leadership in orthopaedics. Hand Innovations added fracture fixation products for the upper extremities, while Future Medical Systems provided arthroscopic fluid management systems and positioned DePuy at the forefront of minimally-invasive techniques in sports medicine. In addition, OrthoMedics, a South African distributor, expanded the company's presence in that region.
In 2007, DePuy Spine acquired assets related to the treatment of vertebral compression fractures from Disc-O-Tech Medical Technologies. These assets included the Confidence System, which consists of a proprietary delivery system and polymethylmethacrylate bone cement that can be injected directly into vertebral bodies to treat compression fractures.
DePuy's most recent acquisitions include Finsbury Orthopaedics, which added new hip, knee, ankle and small joint implants to the DePuy portfolio, especially in the UK market; and Mircus Endovascular, a manufacturer of minimally-invasive devices for haemorrhagic and ischaemic stroke.
DePuy is Johnson & Johnson's largest franchise within its Medical Devices and Diagnostics business, generating sales of almost US$5.6 billion in 2010 and with a global workforce of more than 5,300. It has manufacturing facilities in Indiana, Massachusetts, California and Florida in the US, as well as factories in Ireland, Switzerland, the UK, Germany and China.
This company report provides
Overview
- Key contact information
- Introduction to the company and its current activities
- Summary of its financial performance
- Who are the company's major competitors?
- Key recent events in an “at a glance” format
Financial Review
- Current year and annual financial data, including revenue breakdowns by product area and geographic region (if available)
- Table providing in-depth five-year financial analysis
- Employee data, including breakdown by company division and geographic location
Strategic Focus
- Investigates the company's aims and its areas of focus
Products
- Core product areas, key brands, product approvals and launches Research and Development
- How much has been invested in R&D?
- Where is the research based?
- What alliances and agreements does the company have and with whom?
Manufacturing and Distribution
- Identifying the company's manufacturing locations
- Sales and marketing facilities
Agreements
- With whom has the company reached agreements and what do they involve?
- Key contracts awarded
Mergers, Acquisitions, Minority Investments and Divestments
Litigation
Key Corporate Events
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
|
|
|
